{
    "clinical_study": {
        "@rank": "119372", 
        "acronym": "Heraclitus", 
        "arm_group": [
            {
                "arm_group_label": "Black tea extract", 
                "arm_group_type": "Experimental", 
                "description": "Spray dried aqueous extract of a representative batch of black tea"
            }, 
            {
                "arm_group_label": "Positive control", 
                "arm_group_type": "Active Comparator", 
                "description": "Spray dried aqueous extract of a batch of tea extract that has shown to improve FMD previously"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Food grade colouring, artificial tea flavour and an amount of caffeine matched to the caffeine in the Black tea extract"
            }
        ], 
        "brief_summary": {
            "textblock": "Epidemiological studies indicate that regular consumption of three cups of black tea per day\n      reduces the risk of stroke or myocardial infarction. In a number of previous nutrition\n      intervention studies tea has been shown to improve vascular function as assessed by Flow\n      Mediated Dilation (FMD)."
        }, 
        "brief_title": "Effect of Black Tea on Vascular Function", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Vascular Function", 
        "detailed_description": {
            "textblock": "The current study tests a specific Black tea extract against a placebo in population that\n      has previously show to be sensitive to the effect of black tea on Flow Mediated dilation. A\n      tea extract that has previously been shown to improve FMD is included as the positive\n      control."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Apparently  healthy male volunteers with no history of cardiovascular disease\n\n          -  Having body mass index (BMI) of  between 18.0 and 30.0 kg/m2 (inclusive)\n\n          -  Non-smokers (> 2 years)\n\n          -  Non-tea drinkers (less or equal  1 cup/week)\n\n          -  Limited alcohol intake (less or equal 21 units/week)\n\n          -  Systolic blood pressure less or equal 160 mmHg and/or diastolic blood pressure less\n             or equal 100 mmHg at screening\n\n          -  Brachial artery can be imaged using ultrasound and at screening FMD value is within\n             the expected range as judged by the PI\n\n          -  Judged to be in good health on the basis of medical history, physical examination and\n             routine laboratory tests (total cholesterol, HDL cholesterol, LDL cholesterol,\n             triglycerides, glucose, highly sensitive C-reactive protein)."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01945970", 
            "org_study_id": "REF-BEV-1134"
        }, 
        "intervention": [
            {
                "arm_group_label": "Black tea extract", 
                "description": "Black tea extract", 
                "intervention_name": "Black tea extract", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Positive control", 
                "description": "Positive control", 
                "intervention_name": "Positive control", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Vascular function", 
            "Flow mediated dilation", 
            "Tea"
        ], 
        "lastchanged_date": "December 3, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Pisa", 
                    "country": "Italy"
                }, 
                "name": "Azienda Ospedaliero-Universitaria Pisana, Centro di Farmacologia Clinicaper la Sperimentazione dei Farmaci"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "3", 
        "official_title": "Randomized Double Blind Placebo Controlled Crossover Study to Assess the Effect of Black Tea on Flow-Mediated Dilation in Healthy, Non-tea Drinking Males", 
        "other_outcome": [
            {
                "description": "Blood pressure will be measured before each FMD measurements.", 
                "measure": "The effect on changes in blood pressure (systolic and diastolic will be analysed).", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and  day 8"
            }, 
            {
                "description": "Calculated as for endothelium dependent flow mediated dilation", 
                "measure": "The effects on changes in endothelium-independent dilation (after glyceryl trinitrate).", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and day 8"
            }
        ], 
        "overall_official": {
            "affiliation": "University of Pisa, Internal medicine", 
            "last_name": "Lorenzo Ghiadoni, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The 'acute upon chronic effect' of black tea on flow mediated dilation.", 
            "measure": "Change in flow mediated dilation from baseline on day 1 to post consumption on day 8.", 
            "safety_issue": "No", 
            "time_frame": "Day 1 and day 8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01945970"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The 'acute effect' of black tea extract on flow mediated dilation.", 
                "measure": "Change in flow mediated dilation from baseline on day 1 to post consumption on day 1.", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "The 'chronic effect' of black tea on flow mediated dilation.", 
                "measure": "Change in flow mediated dilation from post consumption on day 1 to post consumption on day 8.", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and day 8"
            }, 
            {
                "description": "The 'acute upon chronic effect' of positive control on flow mediated dilation.", 
                "measure": "Change in flow mediated dilation from baseline on day 1 to post consumption on day 8.", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and day 8"
            }, 
            {
                "description": "The 'acute effect' of positive control on flow mediated dilation.", 
                "measure": "Change in flow mediated dilation from baseline on day 1 to post consumption on day 1.", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "The 'chronic effect' of positive control tea extract on flow mediated dilation", 
                "measure": "Change in flow mediated dilation from post consumption on day 1 to post consumption day 8.", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and day 8"
            }
        ], 
        "source": "Unilever R&D", 
        "sponsors": {
            "collaborator": {
                "agency": "Sprim Advanced Life Sciences", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Unilever R&D", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}